Olanzapine

Product NDC: 0093-5767
11-digit product format: 000935767
Labeler code: 0093
Product ID: 0093-5767_69827204-6016-4105-ba6e-4bbda9a82b78
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Olanzapine
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Teva Pharmaceuticals USA, Inc.
Application: ANDA076000
Marketing category: ANDA
Marketing start: 2011-10-24
Marketing end: 0000-00-00
Substance: OLANZAPINE
Active strength: 3 mg/1
Pharmacologic classes: Atypical Antipsychotic [EPC]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0093-5767		D	Discontinued by firm	2026-10-05
excluded package	package	0093-5767	0093-5767-01	D	Discontinued by firm	2026-10-05
excluded package	package	0093-5767	0093-5767-10	D	Discontinued by firm	2026-10-05
excluded package	package	0093-5767	0093-5767-56	D	Discontinued by firm	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0093-5767-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0093-5767-56	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0093-5767-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0093-5767-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0093-5767-56	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0093-5767-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0093-5767-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0093-5767-56	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0093-5767-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0093-5767-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0093-5767-56	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0093-5767-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0093-5767-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0093-5767-56	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0093-5767-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0093-5767-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0093-5767-56	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0093-5767-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0093-5767-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0093-5767-56	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0093-5767-10	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0093-5767-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0093-5767-56	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0093-5767-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0093-5767-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0093-5767-56	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0093-5767-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0093-5767-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0093-5767-56	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0093-5767-10	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0093-5767-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0093-5767-56	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0093-5767-10	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0093-5767-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0093-5767-56	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0093-5767-10	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A076000-001	OLANZAPINE	OLANZAPINE	2.5MG	TABLET / ORAL	2011-10-24
A076000-002	OLANZAPINE	OLANZAPINE	5MG	TABLET / ORAL	2011-10-24
A076000-003	OLANZAPINE	OLANZAPINE	7.5MG	TABLET / ORAL	2011-10-24
A076000-004	OLANZAPINE	OLANZAPINE	10MG	TABLET / ORAL	2011-10-24
A076000-005	OLANZAPINE	OLANZAPINE	15MG	TABLET / ORAL	2011-10-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 6 · 215 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A076000-001	OLANZAPINE	2.5MG	TABLET / ORAL	2011-10-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076000-002	OLANZAPINE	5MG	TABLET / ORAL	2011-10-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076000-003	OLANZAPINE	7.5MG	TABLET / ORAL	2011-10-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076000-004	OLANZAPINE	10MG	TABLET / ORAL	2011-10-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A076000-005	OLANZAPINE	15MG	TABLET / ORAL	2011-10-24	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A076000-001	OLANZAPINE	2.5MG	TABLET / ORAL	2011-10-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076000-002	OLANZAPINE	5MG	TABLET / ORAL	2011-10-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076000-003	OLANZAPINE	7.5MG	TABLET / ORAL	2011-10-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076000-004	OLANZAPINE	10MG	TABLET / ORAL	2011-10-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076000-005	OLANZAPINE	15MG	TABLET / ORAL	2011-10-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A076000-001	OLANZAPINE	2.5MG	TABLET / ORAL	2011-10-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076000-002	OLANZAPINE	5MG	TABLET / ORAL	2011-10-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076000-003	OLANZAPINE	7.5MG	TABLET / ORAL	2011-10-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076000-004	OLANZAPINE	10MG	TABLET / ORAL	2011-10-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076000-005	OLANZAPINE	15MG	TABLET / ORAL	2011-10-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076000-001	OLANZAPINE	2.5MG	TABLET / ORAL	2011-10-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076000-002	OLANZAPINE	5MG	TABLET / ORAL	2011-10-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076000-003	OLANZAPINE	7.5MG	TABLET / ORAL	2011-10-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076000-004	OLANZAPINE	10MG	TABLET / ORAL	2011-10-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076000-005	OLANZAPINE	15MG	TABLET / ORAL	2011-10-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076000-001	OLANZAPINE	2.5MG	TABLET / ORAL	2011-10-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076000-002	OLANZAPINE	5MG	TABLET / ORAL	2011-10-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076000-003	OLANZAPINE	7.5MG	TABLET / ORAL	2011-10-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076000-004	OLANZAPINE	10MG	TABLET / ORAL	2011-10-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076000-005	OLANZAPINE	15MG	TABLET / ORAL	2011-10-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076000-001	OLANZAPINE	2.5MG	TABLET / ORAL	2011-10-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076000-002	OLANZAPINE	5MG	TABLET / ORAL	2011-10-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076000-003	OLANZAPINE	7.5MG	TABLET / ORAL	2011-10-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076000-004	OLANZAPINE	10MG	TABLET / ORAL	2011-10-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076000-005	OLANZAPINE	15MG	TABLET / ORAL	2011-10-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076000-001	OLANZAPINE	2.5MG	TABLET / ORAL	2011-10-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076000-002	OLANZAPINE	5MG	TABLET / ORAL	2011-10-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076000-003	OLANZAPINE	7.5MG	TABLET / ORAL	2011-10-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076000-004	OLANZAPINE	10MG	TABLET / ORAL	2011-10-24	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076000-005	OLANZAPINE	15MG	TABLET / ORAL	2011-10-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076000-001	OLANZAPINE	2.5MG	TABLET / ORAL	2011-10-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076000-002	OLANZAPINE	5MG	TABLET / ORAL	2011-10-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076000-003	OLANZAPINE	7.5MG	TABLET / ORAL	2011-10-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076000-004	OLANZAPINE	10MG	TABLET / ORAL	2011-10-24	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076000-005	OLANZAPINE	15MG	TABLET / ORAL	2011-10-24	`03ed91905a0d…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A076000-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076000-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076000-003	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076000-004	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076000-005	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A076000-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076000-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076000-003	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076000-004	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076000-005	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A076000-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076000-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076000-003	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076000-004	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076000-005	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A076000-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076000-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076000-003	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076000-004	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076000-005	AB	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
42e9462d-db65-453b-8069-8fb2df9182e8	Product name	1	20211216
12d02c27-e8da-47f1-b815-ccca982731ef	Product name	9	20170802
877783eb-030c-6e3f-0979-804cf94d8856	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0093-5767-01	EA - Each	0093-5767	56444bcb-768e-4235-ad38-7ebda5422ca3	1	2012-07-24
0093-5767-10	EA - Each	0093-5767	aff24aac-045f-4fb5-bf65-031c9665631c	1	2012-07-24
0093-5767-56	EA - Each	0093-5767	d8311c3e-9fd3-45d1-be7c-0ffd54f7cf0b	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
OLANZAPINE	ACTIVE INGREDIENT	N7U69T4SZR	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
OLANZAPINE	ACTIVE MOIETY	N7U69T4SZR	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
CARRAGEENAN	INACTIVE INGREDIENT	5C69YCD2YJ	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
INDIGOTINDISULFONATE SODIUM	INACTIVE INGREDIENT	D3741U8K7L	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
POLYETHYLENE GLYCOL 8000	INACTIVE INGREDIENT	Q662QK8M3B	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OLANZAPINE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC]	8
OLANZAPINE	ACTIVE INGREDIENT	N7U69T4SZR	OLANZAPINE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
OLANZAPINE	ACTIVE MOIETY	N7U69T4SZR	OLANZAPINE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	OLANZAPINE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	OLANZAPINE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
CARRAGEENAN	INACTIVE INGREDIENT	5C69YCD2YJ	OLANZAPINE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	OLANZAPINE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	OLANZAPINE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	OLANZAPINE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OLANZAPINE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	OLANZAPINE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OLANZAPINE TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.]	2
OLANZAPINE	ACTIVE INGREDIENT	N7U69T4SZR	OLANZAPINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	1
Olanzapine	ACTIVE INGREDIENT	N7U69T4SZR	OLANZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]	1
OLANZAPINE	ACTIVE MOIETY	N7U69T4SZR	OLANZAPINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	1
olanzapine	ACTIVE MOIETY	N7U69T4SZR	OLANZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	OLANZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]	1
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	OLANZAPINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	1
CARRAGEENAN	INACTIVE INGREDIENT	5C69YCD2YJ	OLANZAPINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	1
CARRAGEENAN	INACTIVE INGREDIENT	5C69YCD2YJ	OLANZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	OLANZAPINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	OLANZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	OLANZAPINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	OLANZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OLANZAPINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OLANZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]	1
POLYETHYLENE GLYCOL 8000	INACTIVE INGREDIENT	Q662QK8M3B	OLANZAPINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	OLANZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OLANZAPINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OLANZAPINE TABLET, FILM COATED [REBEL DISTRIBUTORS CORP]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
N7U69T4SZR	OLANZAPINE	132539-06-1	OLANZAPINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
312077	OLANZapine 15 MG Oral Tablet	PSN	e3d894b3-5cb6-4aab-bd4a-982f73110c7c	2
200034	OLANZapine 2.5 MG Oral Tablet	PSN	e3d894b3-5cb6-4aab-bd4a-982f73110c7c	2
312079	OLANZapine 7.5 MG Oral Tablet	PSN	e3d894b3-5cb6-4aab-bd4a-982f73110c7c	2
312077	olanzapine 15 MG Oral Tablet	SCD	e3d894b3-5cb6-4aab-bd4a-982f73110c7c	2
200034	olanzapine 2.5 MG Oral Tablet	SCD	e3d894b3-5cb6-4aab-bd4a-982f73110c7c	2
312079	olanzapine 7.5 MG Oral Tablet	SCD	e3d894b3-5cb6-4aab-bd4a-982f73110c7c	2
314154	OLANZapine 10 MG Oral Tablet	PSN	d6a92eba-0841-474b-96f3-778f060ab133	1
200034	OLANZapine 2.5 MG Oral Tablet	PSN	d6a92eba-0841-474b-96f3-778f060ab133	1
312078	OLANZapine 5 MG Oral Tablet	PSN	d6a92eba-0841-474b-96f3-778f060ab133	1
314154	olanzapine 10 MG Oral Tablet	SCD	d6a92eba-0841-474b-96f3-778f060ab133	1
200034	olanzapine 2.5 MG Oral Tablet	SCD	d6a92eba-0841-474b-96f3-778f060ab133	1
312078	olanzapine 5 MG Oral Tablet	SCD	d6a92eba-0841-474b-96f3-778f060ab133	1

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Olanzapine	REMEDYREPACK INC.	2020-04-06	HUMAN PRESCRIPTION DRUG LABEL	4
Olanzapine	Teva Pharmaceuticals USA, Inc.	2017-03-31	HUMAN PRESCRIPTION DRUG LABEL	13
Olanzapine	NCS HealthCare of KY, Inc dba Vangard Labs	2015-05-06	HUMAN PRESCRIPTION DRUG LABEL	1
Olanzapine	Dispensing Solutions, Inc. \| PSS World Medical, Inc.	2013-04-08	HUMAN PRESCRIPTION DRUG LABEL	2
Olanzapine	Rebel Distributors Corp	2012-04-18	HUMAN PRESCRIPTION DRUG LABEL	1